Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Hum Psychopharmacol ; 24(8): 639-45, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19946939

RESUMO

Schizophrenic patients demonstrate a variety of cognitive deficits, including attention, executive functions, and working memory, even in the early stage of disease. In the present study, we examined the association between blood levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA), or brain-derived neurotrophic factor (BDNF) and scores on the Wisconsin Card Sorting Test (WCST) in patients with early-stage schizophrenia. We also investigated the association between frontal GABA levels using 1H-magnetic resonance spectroscopy (MRS) at 3T and scores on the WCST in the same patients. Blood levels of BDNF and catecholamine metabolites and brain GABA levels using 1H-MRS were measured in 18 schizophrenic patients (nine males, nine females; age range 13-52 year). A significantly positive correlation was observed between plasma MHPG levels and %PEM (rho = -0.686, p = 0.0047). A trend toward negative correlation was found between frontal lobe GABA levels and the per cent of preservation error (%PEM) in the early stage of schizophrenia (rho = -0.420, p = 0.0836). These results suggest that noradrenergic neurons might be involved in neuropsychological functions in early-stage of schizophrenia.


Assuntos
Transtornos Cognitivos/fisiopatologia , Metoxi-Hidroxifenilglicol/sangue , Esquizofrenia/fisiopatologia , Ácido gama-Aminobutírico/metabolismo , Adolescente , Adulto , Antipsicóticos/uso terapêutico , Fator Neurotrófico Derivado do Encéfalo/sangue , Transtornos Cognitivos/etiologia , Feminino , Lobo Frontal/metabolismo , Ácido Homovanílico/sangue , Humanos , Espectroscopia de Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Neurônios/metabolismo , Testes Neuropsicológicos , Norepinefrina/metabolismo , Esquizofrenia/sangue , Esquizofrenia/tratamento farmacológico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA